SPY362.06-1.61 -0.44%
DIA296.62-2.62 -0.88%
IXIC12,198.74-7.11 -0.06%

JP Morgan Downgrades GoodRx Holdings to Underweight, Announces $29 Price Target

JP Morgan analyst Doug Anmuth downgrades GoodRx Holdings (NASDAQ:GDRX) from Neutral to Underweight and announces $29 price target.

· 11/18/2020 05:50
JP Morgan analyst Doug Anmuth downgrades GoodRx Holdings (NASDAQ:GDRX) from Neutral to Underweight and announces $29 price target.